Last updated on May 2017

An Investigation of ReNu Knee Injection in Patients With Osteoarthritis


Brief description of study

This is a Prospective, Randomized study evaluating the efficacy of ReNu for the treatment of Kellgren-Lawrence grade 2 or 3 osteoarthritis. Patients will be randomized into 1 of 3 groups for injection into the effected knee: 1) ReNu - study treatment, 2) Hyaluronic Acid (HA) injection - with commonly used injection material and 3) Saline. After treatment, patients will be followed up to 12 months to evaluate improvements using common pain and function subscales.

Clinical Study Identifier: NCT02318511

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Jack Farr, MD

American Sports Medicine Institute
Birmingham, AL United States
  Connect »

Jack Farr, MD

Midwest Orthopedics at Rush, LLC
Chicago, IL United States
  Connect »

Jack Farr, MD

Orthoindy
Indianapolis, IN United States
  Connect »

Christian Latterman, MD

Center for Clinical and Translational Science UK Chandler Medical Center, Pavilion H
Lexington, KY United States
  Connect »

Jack Farr, MD

Brigham and Women's Hospital
Chestnut Hill, MA United States
  Connect »

Seth Sherman, MD

Missouri Orthopaedic Institute (MOI)
Columbia, MO United States
  Connect »

Jack Farr, MD

New Mexico Orthopaedics
Albuquerque, NM United States
  Connect »

Eric Strauss, MD

New York University
New York, NY United States
  Connect »

Sabrina Strickland, MD

Hospital for Special Surgery
New York, NY United States
  Connect »

David Flanigan, MD

The Ohio State University
Columbus, OH United States
  Connect »

Jack Farr, MD

Advanced Orthopedics
Richmond, VA United States
  Connect »